Tiziana life sciences to participate in the h.c. wainwright 25th annual global investment conference

New york, sept. 08, 2023 (globe newswire) -- tiziana life sciences ltd. (nasdaq: tlsa) (“tiziana” or the “company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced that the company will virtually present and host one-on-one meetings at the h.c. wainwright 25th annual global investment conference, being held september 11-13, 2023.
TLSA Ratings Summary
TLSA Quant Ranking